$156.40
1.04%
NYSE, Aug 29, 10:53 pm CET
ISIN
US98978V1035
Symbol
ZTS

Zoetis, Inc. Class A Stock price

$156.40
+5.39 3.57% 1M
-10.84 6.48% 6M
-6.53 4.01% YTD
-26.49 14.48% 1Y
-1.47 0.93% 3Y
-3.70 2.31% 5Y
+111.53 248.56% 10Y
+125.39 404.35% 20Y
NYSE, Closing price Fri, Aug 29 2025
+1.61 1.04%

Key metrics

Basic
Market capitalization
$68.9b
Enterprise Value
$74.0b
Net debt
$5.1b
Cash
$1.4b
Shares outstanding
444.0m
Valuation (TTM | estimate)
P/E
26.7 | 24.4
P/S
7.3 | 7.2
EV/Sales
7.9 | 7.7
EV/FCF
33.3
P/B
13.8
Dividends
DPS
$1.80
Yield 1Y | 5Y
1.2% | 0.8%
Growth 1Y | 5Y
15.4% | 21.0%
Payout 1Y | 3Y
32.8% | 31.3%
Increased
12 Years
Financials (TTM | estimate)
Revenue
$9.4b | $9.6b
EBITDA
$3.7b | $4.2b
EBIT
$3.5b | $3.7b
Net Income
$2.6b | $2.8b
Free Cash Flow
$2.2b
Growth (TTM | estimate)
Revenue
5.3% | 3.9%
EBITDA
9.2% | 17.8%
EBIT
10.0% | 9.2%
Net Income
11.4% | 14.5%
Free Cash Flow
5.5%
Margin (TTM | estimate)
Gross
71.5%
EBITDA
39.1% | 43.3%
EBIT
37.7%
Net
27.8% | 29.6%
Free Cash Flow
23.6%
Financial Health
Equity Ratio
33.5%
Return on Equity
52.1%
ROCE
31.8%
ROIC
23.1%
Debt/Equity
1.3
More
EPS
$5.9
FCF per Share
$5.0
Short interest
1.5%
Employees
14k
Rev per Employee
$670.0k
Show more

Is Zoetis, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Zoetis, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Zoetis, Inc. Class A forecast:

17x Buy
71%
7x Hold
29%

Analyst Opinions

24 Analysts have issued a Zoetis, Inc. Class A forecast:

Buy
71%
Hold
29%

Financial data from Zoetis, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
9,385 9,385
5% 5%
100%
- Direct Costs 2,675 2,675
0% 0%
29%
6,710 6,710
7% 7%
71%
- Selling and Administrative Expenses 2,361 2,361
6% 6%
25%
- Research and Development Expense 682 682
3% 3%
7%
3,671 3,671
9% 9%
39%
- Depreciation and Amortization 134 134
9% 9%
1%
EBIT (Operating Income) EBIT 3,537 3,537
10% 10%
38%
Net Profit 2,612 2,612
11% 11%
28%

In millions USD.

Don't miss a Thing! We will send you all news about Zoetis, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zoetis, Inc. Class A Stock News

Positive
Seeking Alpha
one day ago
Zoetis is a global leader in animal health with strong organic growth, robust product innovation, and strategic M&A driving long-term revenue and earnings expansion. The company boasts exceptional dividend safety, a 13-year double-digit dividend growth streak, and a conservative payout ratio, making it ideal for dividend growth investors. Zoetis's current valuation is slightly below historical ...
Neutral
Business Wire
6 days ago
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8 at 1:05 p.m. ET. Investors and other interested parties can access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-pres...
Positive
Seeking Alpha
8 days ago
Zoetis remains the global leader in animal health, with 68% of revenue from companion animals. Q2 results showed 8% organic sales growth and 15% adjusted earnings growth. Librela sales in the U.S. declined 16% due to reported side effect concerns.
More Zoetis, Inc. Class A News

Company Profile

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

Head office United States
CEO Kristin Peck
Employees 13,800
Founded 1952
Website www.zoetis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today